Discover

ALZN
Alzamend Neuro, Inc.
1.34
2 x 0.98
2 x 1.76
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
1.37 +0.03 (2.31%)
Ytd-26.37%
1y-42.49%
1.34
day range
1.43
0.86
52 week range
2.61
Open1.43Prev Close1.34Low1.34High1.43Mkt Cap6.47M
Vol13.30KAvg Vol88.67KEPS-2.33P/EN/AForward P/E-0.26
Beta-0.04Short Ratio1.03Inst. Own0.94%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0250-d Avg1.60200-d Avg1.551yr Est32.00
Income Statement
Operating Expenses3.03M
Research and Development Expense1.09M
Selling, General and Administrative Expense1.94M
Operating Income-3.03M
Interest Expense2.01K
Net Income-3.03M
Net Income Common Stock-3.03M
Net Income Common Stock (USD)-3.03M
Consolidated Income-3.03M
Earnings per Basic Share-0.68
Earnings per Basic Share (USD)-0.68
Earnings per Diluted Share-0.68
Earning Before Interest & Taxes (EBIT)-3.02M
Earning Before Interest & Taxes (USD)-3.02M
Weighted Average Shares4.48M
Weighted Average Shares Diluted4.48M
Balance Sheet
Cash and Equivalents7.59M
Cash and Equivalents (USD)7.59M
Current Assets8.25M
Property, Plant & Equipment Net287.18K
Total Assets8.54M
Current Liabilities2.74M
Total Liabilities2.74M
Accumulated Retained Earnings (Deficit)-70.33M
Shareholders Equity5.80M
Shareholders Equity (USD)5.80M
Assets Non-Current287.18K
Trade and Non-Trade Payables2.74M
Cash Flow
Depreciation, Amortization & Accretion27.69K
Net Cash Flow from Financing8.02M
Net Cash Flow / Change in Cash & Cash Equivalents6.88M
Issuance (Purchase) of Equity Shares669.27K
Net Cash Flow from Operations-1.14M
Share Based Compensation77.20K